These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20842541)

  • 21. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
    Mummidi V; Jayanthi V
    Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrin.
    Beijnen JH; van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1130-9. PubMed ID: 18663657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
    Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
    Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
    Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preparation and characterization of dihydroartemisinin/ hydroxypropyl-beta-cyclodextrin inclusion complex].
    Chen FW; Guo T; Li HY; Guo Z; He ZG; Shi SL; Zhang JW
    Yao Xue Xue Bao; 2012 Apr; 47(4):529-34. PubMed ID: 22799039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex-Compatibility Study with Pharmaceutical Excipients.
    Sbârcea L; Tănase IM; Ledeți A; Cîrcioban D; Vlase G; Barvinschi P; Miclău M; Văruţ RM; Suciu O; Ledeți I
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33802960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
    J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.
    Cerchiara T; Luppi B; Bigucci F; Zecchi V
    Int J Pharm; 2003 Jun; 258(1-2):209-15. PubMed ID: 12753767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preparation and stuctural behavior of the inclusion complex of beta-cyclodextrin and coptisine hydrochloride].
    Chen HY; Jin Z; Chen SQ
    Zhong Yao Cai; 2012 Jan; 35(1):138-41. PubMed ID: 22734425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions.
    Prajapati M; Eiriksson FF; Loftsson T
    Int J Pharm; 2020 Aug; 586():119579. PubMed ID: 32599134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B; Zhong S; Li N; Li X; Yi J; Jin M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin.
    Yan Z; Xu W; Sun J; Liu X; Zhao Y; Sun Y; Zhang T; He Z
    Drug Dev Ind Pharm; 2008 Jun; 34(6):632-41. PubMed ID: 18568914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex].
    Zhang XN; Yan XY; Tang LH; Gong JH; Zhang Q
    Yao Xue Xue Bao; 2005 Apr; 40(4):369-72. PubMed ID: 16011270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of PVP K30 and/or L-arginine on stability constant of etoricoxib-HPbetaCD inclusion complex: preparation and characterization of etoricoxib-HPbetaCD binary system.
    Shah M; Karekar P; Sancheti P; Vyas V; Pore Y
    Drug Dev Ind Pharm; 2009 Jan; 35(1):118-29. PubMed ID: 18979307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.